Ajanta Pharma surges on tie-up news
DALAL STREET SPIKES
| Ajanta Pharma rose nearly 9 per cent to Rs 108.95 after entering into an exclusive marketing tie-up with Prollenium Medical Technologies, Canada, to market the latter's dermal filler, Revanesse, in India. |
| The total dermatology market in the country is valued at about Rs 1,300 crore. The company believes that Revanesse will make it a frontrunner in the aesthetic segment in the country and boost its corporate equity. |
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 14 2007 | 12:00 AM IST